Literature DB >> 10030478

A review of bipolar disorder among adults.

D M Hilty1, K T Brady, R E Hales.   

Abstract

OBJECTIVE: This paper reviews the epidemiology, etiology, assessment, and management of bipolar disorder. Special attention is paid to factors that complicate treatment, including noncompliance, comorbid disorders, mixed mania, and rapid cycling. Advances in biopsychosocial treatments are briefly reviewed, including new health service models for providing care.
METHODS: A MEDLINE search was done for the period from January 1988 through October 1997 using the key terms of bipolar disorder, diagnosis, and treatment. Papers selected for further review included those published in English in peer-reviewed journals. Preference was given to articles reporting randomized, controlled trials.
RESULTS: Bipolar disorder is a major public health problem. The etiology of the disorder appears multifactorial. Diagnosis often occurs years after onset of the disorder. Comorbid conditions are common. Management includes a lifetime course of medication and attention to psychosocial issues for patients and their families. Standardized treatment guidelines for the management of acute mania have been developed. New potential treatments are being investigated.
CONCLUSIONS: Assessment of bipolar disorder must include careful attention to comorbid disorders and predictors of compliance. Randomized trials are needed to further evaluate the efficacy of medication, psychosocial interventions, and other health service interventions, particularly as they relate to the management of acute bipolar depression, bipolar disorder co-occurring with other disorders, and maintenance prophylactic treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030478     DOI: 10.1176/ps.50.2.201

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  13 in total

1.  Misdiagnosis of bipolar disorder.

Authors:  Tanvir Singh; Muhammad Rajput
Journal:  Psychiatry (Edgmont)       Date:  2006-10

2.  A review of bipolar disorder in adults.

Authors:  Donald M Hilty; Martin H Leamon; Russell F Lim; Rosemary H Kelly; Robert E Hales
Journal:  Psychiatry (Edgmont)       Date:  2006-09

3.  Patients' perceptions of their bipolar illness in a public hospital setting.

Authors:  L E Pollack; M Aponte
Journal:  Psychiatr Q       Date:  2001

4.  The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Authors:  C E Begley; J F Annegers; A C Swann; C Lewis; S Coan; W B Schnapp; L Bryant-Comstock
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.

Authors:  Patrícia R Faustino; Gonçalo S Duarte; Inês Chendo; Ana Castro Caldas; Sofia Reimão; Ricardo M Fernandes; José Vale; Michele Tinazzi; Kailash Bhatia; Joaquim J Ferreira
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

Review 6.  Bipolar disorder in youth.

Authors:  G A Carlson; S E Meyer
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

7.  Lithium and antihypertensive medication: a potentially dangerous interaction.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

8.  Extra dimensions in all aspects of life-the meaning of life with bipolar disorder.

Authors:  Marie Rusner; Gunilla Carlsson; David Brunt; Maria Nyström
Journal:  Int J Qual Stud Health Well-being       Date:  2009-09-01

Review 9.  Women and bipolar disorder across the life span.

Authors:  Dorothy Sit
Journal:  J Am Med Womens Assoc (1972)       Date:  2004

10.  Açaí (Euterpe oleracea Mart.) as a Potential Anti-neuroinflammatory Agent: NLRP3 Priming and Activating Signal Pathway Modulation.

Authors:  Francine Carla Cadoná; Diulie Valente de Souza; Tuyla Fontana; David Frederick Bodenstein; Andiara Prates Ramos; Michele Rorato Sagrillo; Mirian Salvador; Kennya Mota; Carolina Bordin Davidson; Euler Esteves Ribeiro; Ana Cristina Andreazza; Alencar Kolinski Machado
Journal:  Mol Neurobiol       Date:  2021-05-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.